Use first line as column names: yes
Share with everyone: yes
Last edited: Jan 28, 2015
Data on 312 patients with primary biliary cirrhosis, an autoimmune disease that slowly destroys the liver. Patients were randomly assigned to a treatment group that received the drug D-penicillamine or to a control group that received a placebo to see if D-penicillamine would increase their survival time or decrease the level of bilirubin (causes jaundice) in the blood. The liver normally controls the level of bilirubin, but a damaged liver is not able to maintain a healthy level of bilirubin in the blood.
Cirrhosis of the liver can also be caused by alcoholism, but primary biliary cirrhosis is an autoimmune disease not caused by alcoholism.
This data was published in Counting Processes & Survival Analysis, by T.R. Fleming and D.P. Harrington, 1991, New York: Wiley; Appendix D. The data were collected at the Mayo Clinic in Rochester, Minnesota.
This data set has 1 favorites. Sign in to add it to your favorites!
Adding a data set to your favorites makes it easier to come back to in the future!